AHFS Drug Information

11th June 2024

AHFS Drug Information

This update contains 6 new monographs and 44 revised monographs.

New monographs: Atidarsagene Autotemcel; Iloprost (Frostbite); Macitentan and Tadalafil; Pemivibart; Resmetirom; Tislelizumab-jsgr.

Revised monographs: Abatacept; Alemtuzumab (Antineoplastic); Alemtuzumab (Multiple Sclerosis); Alprostadil; Amantadine Hydrochloride (Antiparkinson); Amantadine Hydrochloride (Antiviral); Amiodarone Hydrochloride; Apalutamide; Asciminib Hydrochloride; Binimetinib; Cantharidin; Cisatracurium Besylate; Coagulation Factor IX (recombinant), GlycoPEGylated; Copanlisib Hydrochloride; Dalfampridine; Darolutamide; Darunavir; Dimethyl Fumarate; Diroximel Fumarate; Dostarlimab-gxly; Efgartigimod Alfa; Eflapegrastim-xnst; Emicizumab-kxwh; Erenumab-aooe; Everolimus; fentaNYL, fentaNYL Citrate; Finasteride (BPH); Finasteride (Hair Growth); Fremanezumab-vfrm; Galcanezumab-gnlm; Iloprost; Lopinavir and Ritonavir; Luspatercept-aamt; Nirmatrelvir and Ritonavir; Olaparib; Omaveloxolone; Pegcetacoplan (Geographic Atrophy); Rucaparib Camsylate; Selumetinib Sulfate; Sodium Oxybate; Somatropin; Teplizumab-mzwv; Tretinoin; Ublituximab-xiiy.

14th May 2024

AHFS Drug Information

This update contains 5 new monographs and 26 revised monographs.

New monographs: Berdazimer Sodium; Birch Triterpenes; Brincidofovir; Cefepime Hydrochloride and Enmetazobactam; Lifileucel.

Revised monographs: Abrocitinib; Acalabrutinib; Alpelisib; Amisulpride; Brigatinib; Cabotegravir and Rilpivirine; Cabotegravir Sodium; COVID-19 Vaccine, Adjuvanted (Novavax); COVID-19 Vaccine, mRNA (Moderna); COVID-19 Vaccine, mRNA (Pfizer-BioNTech); Daprodustat; Dasatinib; Dolutegravir Sodium; Faricimab-svoa; Givosiran Sodium; lamiVUDine; Letermovir; Maribavir; Monomethyl Fumarate; Mosunetuzumab-axgb; Odevixibat; Pirtobrutinib; Sarilumab; Tenofovir Alafenamide Fumarate; Valbenazine Tosylate; Vericiguat.

9th April 2024

AHFS Drug Information

This update contains 4 new monographs and 33 revised monographs.

New monographs: Eflornithine Hydrochloride; Sildenafil Citrate (Pulmonary Hypertension); Tadalafil (Pulmonary Hypertension); Taurolidine and Heparin Sodium.

Revised monographs: Abacavir Sulfate; Adagrasib; Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl; Avapritinib; Belimumab; Belzutifan; Cobimetinib Fumarate; Dexmedetomidine Hydrochloride; Dolutegravir Sodium and Lamivudine; Dolutegravir Sodium and Rilpivirine Hydrochloride; Dupilumab; Elexacaftor, Tezacaftor, and Ivacaftor; Fremanezumab-vfrm; Ibalizumab-uiyk; Ivacaftor; Rozanolixizumab-noli; Semaglutide; Sildenafil Citrate (Erectile Dysfunction); Sotorasib; Sparsentan; Tadalafil (Erectile Dysfunction, Benign Prostatic Hyperplasia); Tazemetostat Hydrobromide; Tenofovir Disoproxil Fumarate; Tepotinib Hydrochloride; Tesamorelin Acetate; Tezacaftor and Ivacaftor; Tralokinumab-ldrm; Ubrogepant; Vandetanib; Vismodegib; Vosoritide; Voxelotor ; Zavegepant Hydrochloride.

12th March 2024

AHFS Drug Information

This update contains 5 new monographs, 28 revised monographs, 10 discontinued monographs and 2 new MedWatch alerts.

New monographs: Chikungunya Vaccine Live; Eplontersen Sodium; Exagamglogene Autotemcel; Lovotibeglogene autotemcel; Sotagliflozin.

Revised monographs: Aducanumab; Atogepant; Belumosudil Mesylate; Crizotinib; Deferasirox; Denosumab; Difelikefalin Acetate; Elacestrant Hydrochloride; Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate; Emapalumab; Etravirine; Filgrastim; Fostamatinib Disodium Hexahydrate; inFLIXimab; Lecanemab; Maralixibat Chloride; Mavacamten; Nivolumab and Relatlimab; Norepinephrine Bitartate; Raltegravir Potassium; Ravulizumab; Relugolix, Estradiol, and Norethindrone Acetate; Retifanlimab; Setmelanotide Acetate; Sirolimus (Immunosuppressive Agent); Temsirolimus; Trofinetide; Vonoprazan.

Discontinued monographs: Abciximab; Anti-infectives Available from CDC; COVID-19 Vaccine (Janssen); Eflornithine; HYDROXYprogesterone; Immunization Schedules; Immunobiologic Agents Available from CDC; Measles, Mumps, and Rubella Vaccine; Mobocertinib; Vonoprazan, Clarithromycin, and Amoxicillin.

New MedWatch alerts on the following monographs: Semaglutide; Sotagliflozin.

13th February 2024

AHFS Drug Information

This update contains 11 new monographs, 24 revised monographs, and 9 new MedWatch alerts.

New monographs: ADAMTS13, Recombinant-krhn; Capivasertib; Efbemalenograstim Alfa-vuxw; Fruquintinib; Ipratropium Bromide (EENT); Iptacopan Hydrochloride; levOCARNitine; Meningococcal Groups A, B, C, W, and Y Vaccine; Nirogacestat Hydrobromide; Repotrectinib; Zilucoplan Sodium.

Revised monographs: Alpelisib; Amifampridine Phosphate; Ansuvimab-zykl; Atazanavir Sulfate; Atoltivimab, Maftivimab, and Odesivimab-ebgn; Avalglucosidase Alfa-ngpt; Axitinib; Bictegravir Sodium, Emtricitabine, and Tenofovir Alafenamide Fumarate; Cladribine (Immunomodulatory Agent); Denosumab; Doravirine; Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Fumarate; Entecavir; Fosdenopterin Hydrobromide; Futibatinib; Lenalidomide; Lumasiran Sodium; Ocrelizumab; Pasireotide; Pegcetacoplan; Siponimod Fumarate; Teprotumumab-trbw; Tezepelumab-ekko; Vibegron.

New MedWatch alerts on the following monographs: Axicabtagene Ciloleucel; Brexucabtagene Autoleucel; Ciltacabtagene Autoleucel; cloBAZam; Eflornithine; Idecabtagene Vicleucel; LevETIRAcetam; Lisocabtagene Maraleucel; Tisagenlecleucel.

9th January 2024

AHFS Drug Information

This update contains 9 new monographs, 31 revised monographs, and 2 new MedWatch alerts.

New monographs: Bimekizumab-bkzx; Etrasimod Arginine; Gepirone Hydrochloride; Mirikizumab-mrkz; Nedosiran Sodium; Phentolamine Mesylate; Tenapanor Hydrochloride (Phosphate-removing Agent); Toripalimab-tpzi; Vamorolone.

Revised monographs: Afamelanotide Acetate; AHFS Drug Information® Users Guide; Berotralstat Dihydrochloride; Dabrafenib Mesylate; Editorial Staff; Epoetin Alfa; Finerenone; Ibalizumab-uiyk; Icatibant Acetate; Ixekizumab; Mercaptopurine; Nirsevimab-alip; Notices; Ozanimod Hydrochloride; Pegfilgrastim; Preface; Rifamycin Sodium; Sargramostim; Spesolimab-sbzo; SUFentanil Citrate; Sutimlimab-jome; Tebentafusp-tebn; Tirzepatide; Tremelimumab-actl; Trientine; Trifarotene; Trilaciclib Dihydrochloride; Ustekinumab; Vedolizumab; Viloxazine Hydrochloride; Zuranolone.

New MedWatch alerts on the following monographs: COVID-19 Vaccine, mRNA (Moderna); Insulin Detemir.